# ERDAFITINIB
> **ANDA218578** · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA LTD · Approved 2026-02-02
## Drug
- **FDA Application Number:** ANDA218578
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ERDAFITINIB
- **Generic name:** Erdafitinib
- **Active ingredients:** ERDAFITINIB
- **Dosage form:** TABLET
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** NATCO PHARMA LTD
- **First approval:** 2026-02-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218578)
---
*MORVS · CC0 1.0*